Non-invasive Identification of Colorectal Cancer and Adenomas in Early Stages

Completed

Conditions studied: Colorectal Cancer

In brief

The NICE study is a prospective, multi-site study to train and validate a blood-based, glycoproteomic test for the early detection of advanced adenoma and colorectal cancer by collecting blood samples and associated relevant clinical information from average-risk participants who undergo routine screening colonoscopy as well as participants undergoing colonoscopy for surveillance or diagnostic indications

Key facts

Study ID
NCT05445570
Run by
Venn Biosciences Corporation
People needed
3002
Starts
2022-05-13
Expected to finish
2024-03-19
Last updated by the study team
2024-04-23

Who can join

Age: 45 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.